The ActX mission is to improve health care by making precision medicine practical, thus enabling it to become the standard of care for patients, physicians, and health systems worldwide. We focus on Actionable Genomics℠: evidence-based genetic risks that you can do something about – such as medication use and hereditary risk.
ActX has assembled a team of experts to design the content and technologies necessary to achieve our goal of integrated and effective precision medicine.
Specialties include:
The ActX team is supported by some of the leaders in genetics from around the world.
ActX was founded in 2012 by Dr. Andrew Ury. Dr. Ury founded and was CEO of the first commercial Electronic Medical Record (EMR) company, Practice Partner, in 1983. Practice Partner became one of the most widely used EMR's in the United States and received multiple TEPR Best Electronic Medical Record (EMR/EHR) awards. Practice Partner was acquired by McKesson, a Fortune 15 company, in 2007. Dr. Ury initially was a VP/General Manager at McKesson and then became Chief Medical Officer at McKesson Provider Technologies. Dr. Ury left McKesson in 2009 to found Aucolla.
Dr. Ury is the co-founder of one of the leading practice-based research networks, PPrNet. He has served on advisory panels for the Agency for Healthcare Research and Quality (AHRQ), the National Quality Forum (NQF), and the Joint Commission. He helped found and was twice Vice-Chair of the Electronic Health Record Association (EHRA). He was one of the first Commissioners of the Certification Commission for Health Information Technology (CCHIT). He was the Ernst & Young Northwest Healthcare Entrepreneur of the Year in 2002.
Dr. Ury did his Residency at the University of Washington and is a graduate of Stanford Medical School and Yale University. He has practiced medicine on Vashon Island and in Seattle.